Mangoceuticals (MGRX) Cash from Financing Activities (2023 - 2025)

Mangoceuticals has disclosed Cash from Financing Activities across 3 years of filings, most recently posting $2.1 million for Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at $2.1 million, up 85.61% year-over-year; the trailing twelve-month figure through Dec 2025 was $7.3 million (up 76.12% YoY), and the FY2025 annual result was $7.3 million, up 76.12% from the prior year.
• Cash from Financing Activities came in at $2.1 million for Q4 2025 at Mangoceuticals, up from $1.6 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $5.0 million in Q1 2023 to a low of $267500.0 in Q1 2024.
• The 3-year median for Cash from Financing Activities is $1.3 million (2025), against an average of $1.7 million.
• Across the five-year window, Cash from Financing Activities sank 94.65% in 2024 and surged 754.21% in 2025, its largest moves.
• Mangoceuticals' Cash from Financing Activities stood at $1.2 million in 2023, then fell by 6.46% to $1.1 million in 2024, then surged by 85.61% to $2.1 million in 2025.
• The last three Cash from Financing Activities figures came in at $2.1 million (Q4 2025), $1.6 million (Q3 2025), and $1.3 million (Q2 2025), per Business Quant data.